- Home
- GVH vs CLRB Comparison
GVH vs CLRB Comparison
Compare GVH & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GVH | CLRB |
|---|---|---|
| Founded | 2016 | 2002 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.7M | 12.0M |
| IPO Year | 2023 | 2008 |
Fundamental Metrics
Financial Performance| Metric | GVH | CLRB |
|---|---|---|
| Price | $0.99 | $2.44 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $80.00 | $10.00 |
| AVG Volume (30 Days) | ★ 1.1M | 70.0K |
| Earning Date | 02-17-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $102,768.97 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.74 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.87 | $2.20 |
| 52 Week High | $7.19 | $6.52 |
Technical Indicators
Market Signals| Indicator | GVH | CLRB |
|---|---|---|
| Relative Strength Index (RSI) | 28.78 | 39.78 |
| Support Level | N/A | N/A |
| Resistance Level | $1.79 | $3.03 |
| Average True Range (ATR) | 0.47 | 0.16 |
| MACD | -0.41 | -0.02 |
| Stochastic Oscillator | 2.20 | 15.69 |
Price Performance
Historical ComparisonAbout GVH Globavend Holdings Limited
Globavend Holdings Ltd is an e-commerce logistics provider, it provides integrated cross-border logistics services from Hong Kong to Australia and New Zealand, where it provides customers with a one-stop solution from parcel consolidation to air freight forwarding, customs clearance, on-carriage parcel transportation and delivery. It operates in logistics and freight forwarding industry, which involves the provision of services such as freight transport, freight forwarding, warehouse management, and distribution.
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. The products under development include Iopofosine, CLR 121125 ,CLR 121225 and others. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.